Moreover, the integration of genomic and functional analyses yielded cancer driver mutations in the CSF3R gene in leukemia and identified small molecule kinase inhibitors targeting CSF3R downstream signaling pathways.26 The gene discussed is CSF3R; the disease is leukemia.